Clinical Trials Logo

Nasolabial Fold Wrinkles clinical trials

View clinical trials related to Nasolabial Fold Wrinkles.

Filter by:
  • None
  • Page 1

NCT ID: NCT06013332 Recruiting - Clinical trials for Nasolabial Fold Wrinkles

Polymeric Microspheres vs Sculptra® in the Treatment of Moderate to Severe Nasolabial Folds

Start date: April 15, 2024
Phase: N/A
Study type: Interventional

This is a single-dose, randomized, double-blind, active-controlled, split-face, multiple centers, non-inferiority study. Approximately 50 nasolabial fold subjects will be enrolled. Each enrolled subject will be randomized equally into one of the following groups: 1. Group 1: right face will be injected with PBF PLLA microsphere, and left face with Sculptra® 2. Group 2: right face will be injected with Sculptra® and left face with PBF PLLA microsphere Subjects will be administrated on Visit 1 by applying PBF PLLA microsphere on one side of face and Sculptra® on the other.

NCT ID: NCT05162326 Not yet recruiting - Clinical trials for Nasolabial Fold Wrinkles

BC-101 in Treatment of Nasolabial Fold Wrinkles

Start date: December 1, 2023
Phase: Phase 1
Study type: Interventional

This is an open-label, single-arm, dose-escalating study to evaluate the safety and tolerability of BC-101 administered via subcutaneous/intradermal injection in the treatment of moderate to severe nasolabial folds.

NCT ID: NCT00444353 Completed - Clinical trials for Nasolabial Fold Wrinkles

DL6049 Versus Cosmoplast in the Treatment of Nasolabial Fold Wrinkles, Long Term Follow-up

Start date: August 2004
Phase: Phase 3
Study type: Interventional

This study is being undertaken to: - evaluate the degree of correction attainable with DL6049 (injectable poly-L-lactic acid)compared to a commercially available CosmoPlast™ Collagen Implant in the treatment of dermal nasolabial fold wrinkles at 13 months following the last application of study treatment. - Document the types and incidence of adverse events reported with DL6049 (injectable poly-L-lactic acid)compared with CosmoPlast™ Collagen Implant. Long term adverse events will be assessed for an additional 12 months following discharge from the main study in subjects treated with DL6049.

NCT ID: NCT00444210 Completed - Clinical trials for Nasolabial Fold Wrinkles

DL6049 vs CosmoPlast in the Treatment of Nasolabial Fold Wrinkles

Start date: June 2004
Phase: Phase 3
Study type: Interventional

This study is being undertaken to: - evaluate the degree of correction attainable with DL6049 (injectable poly-L-lactic acid)compared to a commercially available CosmoPlast™ Collagen Implant in the treatment of dermal nasolabial fold wrinkles at 13 months following the last application of study treatment. - Document the types and incidence of adverse events reported with DL6049 (injectable poly-L-lactic acid)compared with CosmoPlast™ Collagen Implant. Long term adverse events will be assessed for an additional 12 months following discharge from the main study in subjects treated with DL6049.